Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Migraine
Placebo responses vary by route of administration in migraine prevention trials. What does this mean?
Christina I. Deligiannia Neurology Department, Athens Naval Hospital, Athens, Greece;b 1st Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian Universtiy of Athens, Athens, Greece
https://orcid.org/0000-0002-6208-1059View further author information
https://orcid.org/0000-0002-6208-1059View further author information, Paolo Martellettic School of Health Sciences, Unitelma Sapienza University of Rome, Rome, Italyhttps://orcid.org/0000-0002-6556-4128View further author information
https://orcid.org/0000-0002-6556-4128View further author information & Dimos D. Mitsikostasb 1st Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian Universtiy of Athens, Athens, GreeceCorrespondence[email protected]
https://orcid.org/0000-0002-4691-3388View further author information
https://orcid.org/0000-0002-4691-3388View further author information